Fulgent Genetics Inc (FLGT) — Capital Reinvestment Ratio
Fulgent Genetics Inc (FLGT) has a Capital Reinvestment Ratio of 0.73x as of March 2026, meaning it reinvests 1% of its operating cash flow ($7.10 Million) in capital expenditures ($5.20 Million). Check FLGT tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fulgent Genetics Inc Capital Reinvestment Ratio (2016–2024)
This chart tracks Fulgent Genetics Inc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Fulgent Genetics Inc cash conversion from operations.
Annual Capital Reinvestment Ratio for Fulgent Genetics Inc (2016–2024)
Year-by-year Capital Reinvestment Ratio for Fulgent Genetics Inc from 2016 to 2024. See Fulgent Genetics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.91x | $21.06 Million | $40.31 Million | ▲ +132.8% |
| 2023 | 0.82x | $27.00 Million | $22.21 Million | ▲ +1010.5% |
| 2022 | 0.07x | $253.52 Million | $18.77 Million | ▲ +67.3% |
| 2021 | 0.04x | $538.58 Million | $23.84 Million | ▼ -82.9% |
| 2020 | 0.26x | $140.63 Million | $36.51 Million | ▲ +21.2% |
| 2019 | 0.21x | $5.52 Million | $1.18 Million | ▼ -94.7% |
| 2017 | 4.02x | $1.33 Million | $5.36 Million | ▲ +367.9% |
| 2016 | 0.86x | $4.41 Million | $3.79 Million | — |